BioLineRx (BLRX)
(Delayed Data from NSDQ)
$0.58 USD
-0.04 (-6.15%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.57 -0.01 (-0.92%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/22/24 |
---|---|
Current Quarter | -0.29 |
EPS Last Quarter | -0.15 |
Last EPS Surprise | 31.82% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.03 |
Next Year | -0.93 |
EPS (TTM) | -0.90 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.34M | 0.47M | 14.37M | 27.77M |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 0.34M | 0.47M | 16.32M | 34.34M |
Low Estimate | 0.34M | 0.47M | 12.41M | 21.20M |
Year ago Sales | 0.00M | 0.00M | 4.80M | 14.37M |
Year over Year Growth Est. | NA | NA | 199.27% | 93.32% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.29 | -0.29 | -1.03 | -0.93 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.29 | -0.29 | -1.03 | -0.93 |
High Estimate | -0.29 | -0.29 | -1.03 | -0.93 |
Low Estimate | -0.29 | -0.29 | -1.03 | -0.93 |
Year ago EPS | -0.15 | -0.30 | -0.94 | -1.03 |
Year over Year Growth Est. | -93.33% | 3.33% | -9.57% | 9.71% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.29 | -0.29 | -1.03 | -0.93 |
7 Days Ago | -0.29 | -0.29 | -1.03 | -0.93 |
30 Days Ago | NA | NA | -0.91 | -0.80 |
60 Days Ago | NA | NA | NA | NA |
90 Days Ago | NA | NA | NA | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.29 | -0.29 | -1.03 | -0.93 |
Zacks Consensus Estimate | -0.29 | -0.29 | -1.03 | -0.93 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.15 | -0.30 | -0.30 | -0.15 | NA |
Estimate | -0.22 | -0.18 | -0.16 | -0.14 | NA |
Difference | 0.07 | -0.12 | -0.14 | -0.01 | -0.05 |
Surprise | 31.82% | -66.67% | -87.50% | -7.14% | -32.37% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more